Ana Beatriz Fagundo-rekin lankidetzan egindako argitalpenak (10)

2016

  1. A Lower Olfactory Capacity Is Related to Higher Circulating Concentrations of Endocannabinoid 2-Arachidonoylglycerol and Higher Body Mass Index in Women

    PLoS ONE, Vol. 11, Núm. 2

  2. Decision making impairment: A shared vulnerability in obesity, gambling disorder and substance use disorders?

    PLoS ONE, Vol. 11, Núm. 9

  3. Modulation of irisin and physical activity on executive functions in obesity and morbid obesity

    Scientific Reports, Vol. 6

  4. Smell–taste dysfunctions in extreme weight/eating conditions: analysis of hormonal and psychological interactions

    Endocrine, Vol. 51, Núm. 2, pp. 256-267

2015

  1. Modulation of higher-order olfaction components on executive functions in humans

    PLoS ONE, Vol. 10, Núm. 6

  2. Olfaction in eating disorders and abnormal eating behavior: a systematic review

    Frontiers in Psychology, Vol. 6

2014

  1. Association of irisin with fat mass, resting energy expenditure, and daily activity in conditions of extreme body mass index

    International Journal of Endocrinology, Vol. 2014

  2. Moderate-vigorous physical activity across body mass index in females: Moderating effect of endocannabinoids and temperament

    PLoS ONE, Vol. 9, Núm. 8

2013

  1. Modulation of the Endocannabinoids N-Arachidonoylethanolamine (AEA) and 2-Arachidonoylglycerol (2-AG) on Executive Functions in Humans

    PLoS ONE, Vol. 8, Núm. 6

2012

  1. Executive functions profile in extreme eating/weight conditions: From Anorexia Nervosa to Obesity

    PLoS ONE, Vol. 7, Núm. 8